valeant pharmaceuticals inte
(VRX:New York)
Executive Profile*
Brian M. StolzChief Human Capital Officer and Executive Vice President of Administration, Valeant Pharmaceuticals International, Inc. |
| Age | Total Calculated Compensation | This person is connected to 0 board members in 0 different organizations across 1 different industries. |
| 36 | -- As of Fiscal Year 2011 |
Background*
Mr. Brian M. Stolz has been an Executive Vice President of Administration and Chief Human Capital Officer at Valeant Pharmaceuticals International, Inc. since June 2011.
Corporate Headquarters*2150 St. Elzéar boulevard WestLaval, Quebec H7L 4A8 Canada Phone: 514-744-6792 Fax: 514-744-6272 Board Members Memberships*There is no Board Members Memberships data available.Education*There is no Education data available.Other Affiliations*There is no Company Affiliations data available. |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |

| Recently Viewed | |||
| VRX:US | $86.50 USD | +0.64 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Paul M. Bisaro | Chief Executive Officer, President and Director Actavis, Inc. | $2.4M |
| Dilip Shantilal Shanghvi | Managing Director, Promoter executive Director and Member of Shareholders/Investors Grievance Committee Sun Pharmaceutical Industries Limited | -- |
| David E. I. Pyott | Chairman, Chief Executive Officer and President Allergan Inc. | $1.3M |
| Howard Solomon | Chairman, Chief Executive Officer and President Forest Laboratories Inc. | $2.4M |
| Flemming Ornskov M.D., MBA, MPH | Chief Executive Officer, Head of Human Genetic Therapies and Director Shire plc | -- | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Bridgewater, MA | Valeant PharmaceuticalsPosted: Jun 16
- Bridgewater, MA | Valeant PharmaceuticalsPosted: Jun 16
- Scottsdale, AZ | Valeant PharmaceuticalsPosted: May 24
- New Jersey | Valeant PharmaceuticalsPosted: May 14
Sponsored Financial Commentaries
Sponsored Links
To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








